Synthesis and biological evaluation of novel pyrazole compounds

被引:42
作者
Youssef, Amal M. [2 ,3 ]
Neeland, Edward G. [2 ]
Villanueva, Erika B. [1 ]
White, M. Sydney [1 ]
El-Ashmawy, Ibrahim M. [4 ]
Patrick, Brian [5 ]
Klegeris, Andis [1 ]
Abd-El-Aziz, Alaa S. [2 ]
机构
[1] Univ British Columbia Okanagan, Dept Biol, Kelowna, BC, Canada
[2] Univ British Columbia Okanagan, Dept Chem, Kelowna, BC, Canada
[3] Univ Alexandria, Fac Pharm, Dept Pharmaceut Chem, Alexandria, Egypt
[4] Univ Alexandria, Fac Vet Med, Dept Pharmacol, Alexandria, Egypt
[5] Univ British Columbia, Xray Facil, Vancouver, BC V5Z 1M9, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Pyrazoles; Anti-inflammatory drugs; Neuroprotection; POTENTIAL PURINE ANTAGONISTS; DNA GYRASE INHIBITORS; P38-ALPHA MAP-KINASE; ANTIBACTERIAL ACTIVITY; CYTO-TOXICITY; DERIVATIVES; AGENTS; PYRAZOLO<3,4-D>PYRIMIDINES; IDENTIFICATION; PROLIFERATION;
D O I
10.1016/j.bmc.2010.06.018
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A novel dipyrazole ethandiamide compound and acid chloride of pyrazolo[3,4-d] pyrimidine 4(5H)-one were prepared and reacted with a number of nucleophiles. The resultant novel compounds were tested in several in vitro and in vivo assays. Three compounds inhibited the secretion of neurotoxins by human THP-1 monocytic cells at concentrations that were not toxic to these cells. They also partially inhibited both cyclooxygenase-1 and -2 isoforms. In animal studies, two compounds were notable for their anti-inflammatory activity that was comparable to that of the clinically available cyclooxygenase-2 inhibitor celecoxib. Modeling studies by using the molecular operating environment module showed comparable docking scores for the two enantiomers docked in the active site of cyclooxygenase-2. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5685 / 5696
页数:12
相关论文
共 56 条
[41]   Regioselective synthesis of novel substituted pyrazolo[1,5-a]pyrimidines under solvent-free conditions [J].
Quiroga, Jairo ;
Portilla, Jaime ;
Abonia, Rodrigo ;
Insuasty, Braulio ;
Nogueras, Manuel ;
Cobo, Justo .
TETRAHEDRON LETTERS, 2008, 49 (43) :6254-6256
[42]   Pyrazoloheteroaryls:: Novel p38α MAP kinase inhibiting scaffolds with oral activity [J].
Revesz, L ;
Blum, E ;
Di Padova, FE ;
Buhl, T ;
Feifel, R ;
Gram, H ;
Hiestand, P ;
Manning, U ;
Neumann, U ;
Rucklin, G .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (02) :262-266
[43]   THE GRANULOMA POUCH AS A ROUTINE ASSAY FOR ANTIPHLOGISTIC COMPOUNDS [J].
ROBERT, A ;
NEZAMIS, JE .
ACTA ENDOCRINOLOGICA, 1957, 25 (01) :105-112
[45]   Design and synthesis of some thiazolyl and thiadiazolyl derivatives of antipyrine as potential non-acidic anti-inflammatory, analgesic and antimicrobial agents [J].
Rostom, Sherif A. F. ;
El-Ashmawy, Ibrahim M. ;
El Razik, Heba A. Abd ;
Badr, Mona H. ;
Ashour, Hayam M. A. .
BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (02) :882-895
[46]   Prevention of Alzheimer's disease-associated Aβ aggregation by rationally designed nonpeptidic β-sheet ligands [J].
Rzepecki, P ;
Nagel-Steger, L ;
Feuerstein, S ;
Linne, U ;
Molt, O ;
Zadmard, R ;
Aschermann, K ;
Wehner, M ;
Schrader, T ;
Riesner, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (46) :47497-47505
[47]   Aminopyrazole oligomers for β-sheet stabilization of peptides [J].
Rzepecki, P ;
Wehner, M ;
Molt, O ;
Zadmard, R ;
Harms, K ;
Schrader, T .
SYNTHESIS-STUTTGART, 2003, (12) :1815-1826
[48]  
Saggar S., 2007, US. Patent. Appl, Patent No. [US 20070214422007, 20070214422007]
[49]   HEILMITTELCHEMISCHE UNTERSUCHUNGEN IN DER HETEROCYCLISCHEN REIHE .14. PYRAZOLO-(3,4-D)-PYRIMIDINE [J].
SCHMIDT, P ;
DRUEY, J .
HELVETICA CHIMICA ACTA, 1956, 39 (03) :986-991
[50]   Antinociceptive effect of novel pyrazolines in mice [J].
Tabarelli, Z ;
Rubin, MA ;
Berlese, DB ;
Sauzem, PD ;
Missio, TP ;
Teixeira, MV ;
Sinhorin, AP ;
Martins, MAP ;
Zanatta, N ;
Bonacorso, HG ;
Mello, CF .
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2004, 37 (10) :1531-1540